| (Values in U.S. Thousands) | Jun, 2016 | Jun, 2015 | Jun, 2014 | Jun, 2013 | Jun, 2026 |
| Sales | 9,970 | 0 | 170 | 80 | 0 |
| Sales Growth | unch | -100.00% | +112.50% | unch | unch |
| Net Income | 670 | -13,500 | 5,490 | -30,320 | 0 |
| Net Income Growth | +104.96% | -345.90% | +118.11% | unch | unch |
Bioniche Life Scienc (BNHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Telesta Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development, manufacturing and commercialization of transformative human therapeutics. Its lead product candidate consists of mycobacterial cell wall-nucleic acid complex, a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans which is in clinical trial. Telesta Therapeutics Inc. is headquartered in Pointe-Claire, Canada.
Fiscal Year End Date: 06/30